Citius Pharmaceuticals, Inc.CTXRNASDAQ
Loading
Interest Expense Over TimeExpanding
Percentile Rank93
5Y CAGR+108.1%
Studio
Year-over-Year Change

Interest expense on outstanding debt

5Y CAGR
+108.1%/yr
Long-term compound
Percentile
P93
Near historical high
vs 5Y Ago
39.1x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$423320.00+58.1%
2025$267782.00-
2024$0.00-
2023$0.00-100.0%
2022$251399.00+2219.4%
2021$10839.00-30.8%
2020$15673.00-4.7%
2019$16443.00+3.8%
2018$15838.00-98.1%
2017$850789.00-